Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, digestive system disorder, digestive system neoplasm, gastrointestinal stromal tumor, neoplasmRecruitingPhase 22026-08-10NCT07406633

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Kumquat Biosciences Inc.7

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Cleveland ClinicClevelandUnited States558
Dana-Farber Cancer InstituteBostonUnited States626
Fox Chase Cancer CenterPhiladelphiaUnited States259
Fred Hutchinson Cancer CenterSeattleUnited States250
Huntsman Cancer InstituteSalt Lake CityUnited States107
Mayo Clinic - JacksonvilleJacksonvilleUnited States25
Mayo Clinic - RochesterRochesterUnited States59
Moffitt Cancer CenterTampaUnited States523
Northwell Health/R.J. Zuckerberg Cancer CenterLake SuccessUnited States2
Oregon Health & Science UniversityPortlandUnited States261
Sylvester Comprehensive Cancer CenterMiamiUnited States37
University of Chicago Medical CenterChicagoUnited States152
University of Iowa Health CareIowa CityUnited States47
University of Michigan HospitalsAnn ArborUnited States10
University of North Carolina at Chapel HillChapel HillUnited States129
Usc Norris Comprehensive Cancer CenterLos AngelesUnited States67
UT MD Anderson Cancer CenterHoustonUnited States204